The Spanish Familial Hypercholesterolaemia Cohort Study
ConditionFamilial Hypercholesterolaemia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age15+
SponsorFundación Hipercolesterolemia Familiar
About this trial
SAFEHEART is a large, on-going registry study in molecularly defined patients with heterozygous FH treated in Spain.
Eligibility criteria
Qualifiers
Index cases with genetic diagnosis of FH and their relatives over 15 years old with a genetic diagnosis of FH and their first-degree relatives
Disqualifiers
Patient unwillingness
Trial design
Treatments tested in this trial
- Not listed
Trial groups
4,141 Participants
are grouped into 2 trial groupsSponsors and collaborators
Fundación Hipercolesterolemia Familiar
Lead sponsor
Instituto de Salud Carlos III
Collaborator
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Collaborator
Source ClinicalTrials.gov